Evaluation of Macitentan in Patients With Eisenmenger Syndrome: Results From the Randomized, Controlled MAESTRO Study

BACKGROUND: Eisenmenger syndrome describes congenital heart disease-associated severe pulmonary hypertension accompanied by right-to-left shunting. The multicenter, double-blind, randomized, placebo-controlled, 16-week, phase III MAESTRO study (Macitentan in Eisenmenger Syndrome to Restore Exercise...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatzoulis, Michael A., Landzberg, Michael, Beghetti, Maurice, Berger, Rolf M., Efficace, Michela, Gesang, Sophie, He, Jian’guo, Papadakis, Kelly, Pulido, Tomás, Galiè, Nazzareno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314514/
https://www.ncbi.nlm.nih.gov/pubmed/30586694
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.033575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314514/
https://www.ncbi.nlm.nih.gov/pubmed/30586694
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.033575

Ejemplares similares